Clinical Research Directory
Browse clinical research sites, groups, and studies.
To Study the Efficacy of Intravenous Neostigmine in Resolution of Acute GI Paralysis in Critically Ill Cirrhotics
Sponsor: Institute of Liver and Biliary Sciences, India
Summary
Aim: To determine the efficacy of intravenous neostigmine in the resolution of acute GI paralysis in patients with Critically Ill Cirrhosis (CIC). Study population: Critically ill cirrhosis patient admitted in liver ICU with new onset acute GI tract paralysis and develop feed intolerance. Study period - 1 years Sample Size • All the consecutive patients admitted in liver ICU during the study time period (Dec 2023 -September 2024) will be screened and those patients meeting with inclusion and exclusion criteria will be enrolled, we intend to enroll 70 patients for the study.
Official title: To Study the Efficacy of Intravenous Neostigmine in Resolution of Acute GI Paralysis in Critically Ill Cirrhotics-Prospective Observational Study
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
OBSERVATIONAL
Enrollment
48
Start Date
2024-06-15
Completion Date
2025-02-27
Last Updated
2024-06-17
Healthy Volunteers
No
Conditions
Interventions
observational study
It is an observational study
Locations (1)
Institute of Liver & Biliary Sciences
New Delhi, National Capital Territory of Delhi, India